Yellow Jersey Therapeutics
Switzerland
unknown
unknown
Stage
1
Investors
About
Yellow Jersey Therapeutics is a Swiss biotechnology company developing antibody-based therapeutics targeting immune checkpoints for cancer treatment.
Explore Yellow Jersey Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.